Medication-Assisted Treatment: Overcoming Barriers to Improve Access for Patients

October 21, 2020
1-2 PM CDT

As regulators continue the fight against the opioid epidemic, the next step is ensuring medication-assisted treatment (MAT) is available for those patients suffering with opioid use disorder (OUD). Unfortunately, few OUD patients have access to MAT due to barriers such as limited access to treatment, the social stigma, cost, and lack of education. The federal government has prioritized expanding access to MAT as an important element in reducing OUDs and overdoses. Because pharmacists are among the most accessible and trusted health care providers, they are in a unique position to provide OUD patients with essential care through MAT.

This webinar will discuss the patient’s struggle with addiction and recovery, as well as steps states are taking to increase MAT access. NABP President Timothy Fensky will also provide an overview of his presidential initiative to increase access to pharmacist-provided MAT to those suffering from OUD.



Timothy Fensky, RPh, DPh, FACA, NABP President, Massachusetts Board of Pharmacy Member

Mr Fensky, a member of the Massachusetts Board of Registration in Pharmacy, is serving as NABP president. He has served one-year terms as president-elect and treasurer and a two-year term as an Executive Committee member. He currently represents NABP on the Pharmacy Compounding Advisory Committee to the United States Food and Drug Administration. He is the pharmacy administrator at Bournewood Health Systems and the chief pharmacy officer at Sullivan’s Health Care. He is recognized as a full fellow for the American College of Apothecaries and is an adjunct faculty member at both the Massachusetts College of Pharmacy and Health Sciences and Northeastern University, Bouvé College of Pharmacy and Health Sciences.

Erica Schlesinger, PharmD, Assistant Chief Pharmacist, Tennessee Department of Mental Health and Substance Abuse Services

Dr Erica Schlesinger is a West Tennessee native and graduate of the University of Tennessee Health Science Center College of Pharmacy (2017). She completed a PGY-1 managed care residency with the Tennessee Department of Mental Health and Substance Abuse Services and the University of Tennessee. Dr Schlesinger is currently the assistant chief pharmacist for the Tennessee Department of Mental Health and Substance Abuse Services. Her current interests and career goals are centered around health and mental health policy, mental health and addiction treatment and education, and health care informatics.

Jake Nichols, PharmD, MBA, Principal, Clinical Product Strategy at axialHealthcare, Specialist in Medications for Addiction Treatment

Jake Nichols is a pharmacist in long‐term recovery with extensive experience in community pharmacy, academia, primary care, managed care, and pharmaceutical industry. He specializes in the treatment of substances use disorders with a focus on medication for addiction treatment. Dr Nichols speaks regularly at conferences across the country, highlighting his experiences as a patient along with the importance and value of treatment. Through his 15‐year struggle with substance use, he found his calling in the field and has dedicated his career to helping patients and their families suffering from this debilitating chronic disease. By providing clinical support for clinicians treating patients with substance use disorder and serving as a vocal advocate for treatment, Dr Nichols has established himself as a key resource within the field. He has spoken at well over 200 pharmacy, nursing, and medical schools across the country, sharing his story with students and faculty. He also regularly facilitates patient and parent support groups. In 2017 he established his own education, clinical consulting, and treatment group called Professional Recovery Associates, of which he is President and CEO. Dr Nichols received his doctor of pharmacy degree from the Massachusetts College of Pharmacy in 2000 and his master’s degree in business administration from University of Massachusetts – Boston in 2007. Jake is currently employed as clinical lead for substance use disorder at Axial Healthcare in Nashville, TN.
CPE Credit

The complimentary webinar is eligible for Accreditation Council for Pharmacy Education (ACPE)-accredited continuing pharmacy education (CPE) credit. More details regarding the presentations, CPE activity credits, and browser requirements can be found in the CPE Activity Information Guide.

View the handout for this presentation.



Defending Data in the Digital Age: Understanding Cybercrime in Healthcare

August 19, 2020
1-2 PM CDT

In our technology rich world, cyber attacks on personal and workplace data have become increasingly rampant. The healthcare industry is no stranger to cybercrime especially amid the COVID-19 pandemic as attackers prey on vulnerable consumers. As the number of professionals working from home increases, the need for innovative cybersecurity tactics has even greater importance. In this live webinar, cybersecurity and technology experts will discuss best practices to safeguard personal and workplace information from cybercrime.


Paul Luehr, Partner at Faegre Drinker 

Paul Luehr partners with clients to optimize their privacy and cybersecurity practices, from risk management to incident response. As the leader of the firm’s privacy and cybersecurity team, Paul understands that cybersecurity crises can be profoundly costly, and they can strike organizations across a wide range of industries. Drawing from 25 years on the cutting edge of data privacy and cybersecurity — including experience investigating and prosecuting cybercrimes with the Federal Trade Commission (FTC) and the Department of Justice (DOJ) — Paul helps clients avoid becoming a cautionary tale. He has led investigations into several of the top data breaches on record.

Paul has overseen forensic teams on data incidents affecting national retailers, financial institutions, hospitals and national health care companies, universities, hotel chains, defense contractors, and online providers. Paul’s insights have been featured on CBS, NBC, CNBC and BBC television, and in The Wall Street Journal, The New York Times and USA Today.

Doriann Cain, Associate at Faegre Drinker

Doriann Cain works with clients to enhance their privacy and cybersecurity practices from compliance to incident response.

Doriann’s experience includes advising clients on a variety of privacy and security laws, including the California Consumer Privacy Act (CCPA), the General Data Protection Regulation (GDPR), the Gramm-Leach-Bliley Act (GLBA), the Health Insurance Portability and Accountability Act (HIPAA), and state breach notification statutes. Doriann is well-versed in drafting data use agreements, business associate agreements, and internal privacy and security policies and procedures, conducting privacy and security training, negotiating privacy and cybersecurity aspects of cloud computing and other sourcing arrangements, as well as assessing privacy and security vulnerabilities in proposed transactions. Notably, Doriann is a Certified Information Privacy Professional (CIPP/US) in the laws of the United States for the private sector.

James Schuetz, Security Architect at NABP

James Schuetz is a security architect, who works with NABP to protect its information systems. After spending more than a decade guiding healthcare organizations through the evolving cybersecurity landscape, James understands the risks posed to sensitive data and what is required to defend it. James specializes in leveraging cutting-edge technologies to identity and prevent emerging threats. He promotes that every individual should understand the value in their data and actively protect it.


View the handout for the presentation.


The CBD Explosion – Keeping Out of Harm’s Way

July 15, 2020
1-2 PM CDT

Since the legalization of hemp, the sale of cannabidiol (CBD) product has exploded everywhere, from pharmacies to gas stations. Consumers can find CBD in an ever-growing variety of products, from an FDA-approved drug to dietary supplements and topicals, but are they all legal? Science has shown there are numerous pharmacological effects on many physiological systems in the human body, but what about the potential for interacting with other drugs? What do regulatory bodies, such as the boards of pharmacy, and pharmacists need to know to protect the public from harm? Experts on CBD provided webinar attendees the facts on CBD pharmacology, as well as the regulatory landscape in the United States and whether this explosion can be controlled.


Ken Mackie, MD

Linda and Jack Gill Chair of Neuroscience and Distinguished Professor Department of Psychological & Brain Sciences at Indiana University

Justin Macy, PharmD, JD

Digital Health Senior Manager at NABP  

Niamh Lewis, JD

Digital Health Regulatory Expert at NABP

CPE Credit

The complimentary webinar is eligible for Accreditation Council for Pharmacy Education (ACPE)-accredited continuing pharmacy education (CPE) credit. More details regarding the presentations, CPE activity credits, and browser requirements can be found in the CPE Activity Information Guide.

View the handout for the presentation.


Virtual Educational Poster Sessions 1 & 2: Uniting to Protect the Public Health

June 16 & 23, 2020

The annual Educational Poster Session, which was held as a two-part webinar series this year, provided an opportunity to interact virtually with presenters and earn continuing pharmacy education credit. Board of pharmacy and school and college of pharmacy representatives presented various poster displays related to working together to educate on pharmacy practices in furtherance of protecting the public health.

Session One PRESENTATIONS (June 16)
  • “Facing the Crisis and Looking Forward”
  • “Preventative Measures for HIV Vulnerable Patients in the LGBTQ+ Community”
  • “Outbreak Ready Initiative: Pharmacists Ensuring Community Resilience Amid the Coronavirus”
  • “Maximizing HPV Vaccination Rates through Community Pharmacist Utilization”
  • “ONE Rx: Community Pharmacy Based Screening and Interventions for Opioid Misuse and Accidental Overdose”

View handouts for the session one presentations.

Session Two PRESENTATIONS (June 23)
  • “Pharmacists Enhancing Expedited Partner Therapy in the District of Columbia”
  • “Standard of Care: A National Three Profession Survey of Health Care State Agencies”
  • “Expanding the Pharmacist’s Role in The Opioid Epidemic with Pharmacogenomics”
  • “Expanding the Roles of Pharmacy Technicians: Why Not North Dakota?”

View handouts for the session two presentation. 


The complimentary webinar is eligible for Accreditation Council for Pharmacy Education (ACPE)-accredited continuing pharmacy education (CPE) credit. More details regarding the presentations, CPE activity credits, and browser requirements, can be found in the CPE Activity Information Guide. Information about the learning objectives is also available for each presentation.